ADVERTISEMENT

Medical News

New COVID-19 vaccine on the horizon

Heather Mason   |   25 October 2021

Recent results from a phase 3 randomised, observer-blind, head-to-head immunogenicity trial show that the inactivated SARS-CoV-2 whole virus adjuvanted vaccine (VLA2001) is superior to the  AstraZeneca vaccine ( AZD1222) for geometric mean titre (GMT) for neutralising antibodies 

The trial included 2972 participants aged ≥30 years, randomised (2:1) to receive two...

          

November Challenge

Ends in 10h
left
right

Topic Challenges

left
right